Amy Lynnette Van Deusen, M.S.
|2005-2007||Pharmacology||University of Virginia, Charlottesville, VA|
|2007-2008||Cell Biology||University of California – Irvine|
|2010-2011||CICBDD||University of North Carolina Eshelman School of Pharmacy|
|2013-2014||MRC||University of Edinburgh, Edinburgh, Scotland, United Kingdom|
|2016-||Neuroscience||University of Virginia School of Medicine, Charlottesville, VA, United States|
Area:Neuroscience, Regenerative Medicine, Stem Cells, Neural Development
Google:"Amy Van Deusen"
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Canham MA, Van Deusen AL, Brison DR, et al. (2015) The molecular karyotype of 25 clinical-grade human embryonic stem cell lines Scientific Reports|
|Oliver-Vila I, Van Deusen AL, Palau R, et al. (2015) Quality compliance in the development of cell-based medicines in non-pharma environments Bmc Proceedings|
|Liu J, Yang C, Simpson C, et al. (2012) Discovery of small molecule Mer kinase inhibitors for the treatment of pediatric acute lymphoblastic leukemia Acs Medicinal Chemistry Letters|
|Christoph S, DeRyckere D, Sather S, et al. (2011) UNC569 as novel small molecule mer receptor tyrosine kinase inhibitor for treatment of ALL Blood|
|Perez-Reyes E, Van Deusen AL, Vitko I. (2009) Molecular pharmacology of human Cav3. 2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs Journal of Pharmacology and Experimental Therapeutics. 328|
|Arias-Olguín I, Vitko I, Fortuna M, et al. (2008) Characterization of the gating brake in the I-II loop of Cav3. 2 T-type Ca2+ channels Journal of Biological Chemistry|
|Nelson MT, Joksovic PM, Su P, et al. (2007) Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate Journal of Neuroscience. 27: 46|
|Xie X, Van Deusen AL, Vitko I, et al. (2007) Validation of high throughput screening assays against three subtypes of Cav3 T-type channels using molecular and pharmacologic approaches Assay and Drug Development Technologies|